Distinct association of admission hyperglycemia with one-year adverse outcome in diabetic and non-diabetic patients with acute ST-elevation myocardial infarction

Hellenic Journal of Cardiology

Volumn 54, Issue 2, 2013, Pages 119-125

  Lazaros, George ^a   Tsiachris, Dimitris ^a   Vlachopoulos, Charalambos ^a   Chrysohoou, Christina ^a   Milkas, Anastasios ^a   Papageorgiou, Nikos ^a   Tousoulis, Dimitris ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Glycometabolic state; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL ANALYSIS;

EID: 84878183290     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet. 1984; 1: 1264-1267.
2. Fava S, Aquilina O, Azzopardi J, Agius Muscat H, Fenech FF. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet Med. 1996; 13: 80-83.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyper-glycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355: 773-778.
4. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004; 21: 305-310.
5. Dirkali A, van der Ploeg T, Nangrahary M, Cornel JH, Umans VA. The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction. Int J Cardiol. 2007; 121: 215-217.
6. Straumann E, Kurz DJ, Muntwyler J, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J. 2005; 150: 1000-1006.
7. Schiele F, Descotes-Genon V, Seronde MF, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med. 2006; 23: 1370-1376.
8. Ishihara M, Kojima S, Sakamoto T, et al. Acute hyperglyce-mia is associated with adverse outcome after acute myocar-dial infarction in the coronary intervention era. Am Heart J. 2005; 150: 814-820.
9. Pissimissis EG, Garoufalis SE. Prognosis and management of diabetic patients with acute coronary syndrome. Hellenic J Cardiol. 2005; 46: 139-147.
10. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008; 117: 1610-1619.
11. Ishihara M, Kojima S, Sakamoto T, et al. Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol. 2009; 104: 769-774.
12. Petursson P, Herlitz J, Caidahl K, et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol. 2007; 116: 315-320.
13. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005; 22: 1321-1325.
14. Lazaros G, Tsiachris D, Tousoulis D, et al. In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction. Int J Cardiol. 2012; 155: 97-101.
15. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50: 2173-2195.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470.
17. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006; 29 SUPPL. 1: S43-S48.
18. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008; 51: 210-247.
19. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40: 1748-1754.
20. Vetter NJ, Strange RC, Adams W, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet. 1974; 1: 284-288.
21. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006; 295: 1681-1687.
22. Shechter M, Merz CN, Paul-Labrador MJ, Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol. 2000; 35: 300-307.
23. Kersten JR, Toller WG, Tessmer JP, Pagel PS, Warltier DC. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol. 2001; 281: H2097-H2104.
24. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsu-linemia. Circulation. 2000; 101: 2247-2251.
25. Toutouzas K, Markou V, Drakopoulou M, Mitropoulos I, Tsiamis E, Stefanadis C. Patients with type two diabetes mel-litus: increased local inflammatory activation in culprit ather-omatous plaques. Hellenic J Cardiol. 2005; 46: 283-288.
26. Diakakis GF, Parthenakis FI, Mavrakis HE, et al. Association of impaired glucose tolerance with increased heart rate and subclinical inflammation. Hellenic J Cardiol. 2005; 46: 394-401.
27. Iwakura K, Ito H, Ikushima M, et al. Association between hy-perglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003; 41: 1-7.
28. Ishihara M, Inoue I, Kawagoe T, et al. Impact of acute hyper-glycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J. 2003; 146: 674-678.
29. Chrysohoou C, Pitsavos C, Aggelopoulos P, et al. Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: the Hellenic Heart Failure Study. Heart Vessels. 2010; 25: 209-216.
30. Shiomi T, Tsutsui H, Ikeuchi M, et al. Streptozotocin-in-duced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol. 2003; 42: 165-172.